Indian Medicines Pharmaceutical Corporation Profile
Key Indicators
- Authorised Capital ₹ 75.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 51.98 Cr
as on 23-10-2024
- Company Age 46 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 23-10-2024
- Revenue -14.08%
(FY 2023)
- Profit -38.36%
(FY 2023)
- Ebitda -34.13%
(FY 2023)
- Net Worth 8.71%
(FY 2023)
- Total Assets -13.20%
(FY 2023)
About Indian Medicines Pharmaceutical Corporation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 75.00 Cr and a paid-up capital of Rs 51.98 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
The Key Managerial Personnel (KMP) at Indian Medicines Pharmaceutical Corporation Limited India are Arvind Aggarwal as CFO and Pankaj Jha as Company Secretary. Manoj Nesari, Mukesh Kumar, and Sarakanuru Srinath serve as directors at the Company.
- CIN/LLPIN
U24231UR1978GOI004637
- Company No.
004637
- Company Classification
Private Limited Union Government Company
- Incorporation Date
12 Jul 1978
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Almora, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Indian Medicines Pharmaceutical Corporation Limited offer?
Indian Medicines Pharmaceutical Corporation Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Common Disease Medicines, Pharmaceutical Syrup.
Who are the key members and board of directors at Indian Medicines Pharmaceutical Corporation?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Kumar  | Managing Director | 06-Jul-2020 | Current |
| Arvind Aggarwal | CFO | 15-Jun-2022 | Current |
| Pankaj Jha | Company Secretary | 06-Nov-2013 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Nesari | Nominee Director | 24-Jul-2024 | Current |
| Sarakanuru Srinath | Director | 20-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Indian Medicines Pharmaceutical Corporation.
Indian Medicines Pharmaceutical Corporation Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.08% decrease. The company also saw a substantial fall in profitability, with a 38.36% decrease in profit. The company's net worth moved up by a moderate rise of 8.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Medicines Pharmaceutical Corporation?
In 2023, Indian Medicines Pharmaceutical Corporation had a promoter holding of 98.11% and a public holding of 1.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Feb 2007 | ₹3.00 Cr | Open |
How Many Employees Work at Indian Medicines Pharmaceutical Corporation?
Indian Medicines Pharmaceutical Corporation has a workforce of 96 employees as of Oct 15, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Medicines Pharmaceutical Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Medicines Pharmaceutical Corporation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
